Cargando…
P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767928/ http://dx.doi.org/10.1186/1742-4690-6-S3-P411 |
| _version_ | 1782173410848145408 |
|---|---|
| author | Overton, T Schmidt, D Hain, J Virgin, G Steigerwald, R Dirmeier, U Jordan, E Meyer, T Young, P Ludvigsen, A Nichols, R Chaplin, P |
| author_facet | Overton, T Schmidt, D Hain, J Virgin, G Steigerwald, R Dirmeier, U Jordan, E Meyer, T Young, P Ludvigsen, A Nichols, R Chaplin, P |
| author_sort | Overton, T |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2767928 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27679282009-10-28 P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response Overton, T Schmidt, D Hain, J Virgin, G Steigerwald, R Dirmeier, U Jordan, E Meyer, T Young, P Ludvigsen, A Nichols, R Chaplin, P Retrovirology Poster Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767928/ http://dx.doi.org/10.1186/1742-4690-6-S3-P411 Text en Copyright © 2009 Overton et al; licensee BioMed Central Ltd. |
| spellingShingle | Poster Presentation Overton, T Schmidt, D Hain, J Virgin, G Steigerwald, R Dirmeier, U Jordan, E Meyer, T Young, P Ludvigsen, A Nichols, R Chaplin, P P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response |
| title | P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response |
| title_full | P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response |
| title_fullStr | P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response |
| title_full_unstemmed | P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response |
| title_short | P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response |
| title_sort | p18-12 lb. phase i clinical trial with a new recombinant mva-bn(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767928/ http://dx.doi.org/10.1186/1742-4690-6-S3-P411 |
| work_keys_str_mv | AT overtont p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT schmidtd p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT hainj p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT virging p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT steigerwaldr p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT dirmeieru p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT jordane p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT meyert p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT youngp p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT ludvigsena p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT nicholsr p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse AT chaplinp p1812lbphaseiclinicaltrialwithanewrecombinantmvabnmultiantigenvaccinehighresponderrateandconsiderablebreadthofimmunologicalresponse |